Impact of smoking on gestational diabetes mellitus and offspring birthweight in primiparous women by Masalin, Senja et al.
1632  |    Acta Obstet Gynecol Scand. 2020;99:1632–1639.wileyonlinelibrary.com/journal/aogs
 
Received: 25 November 2019  |  Revised: 14 May 2020  |  Accepted: 19 May 2020
DOI: 10.1111/aogs.13924  
O R I G I N A L  R E S E A R C H  A R T I C L E
Impact of smoking on gestational diabetes mellitus and 
offspring birthweight in primiparous women
Senja Masalin1,2  |   Hannu Kautiainen3,4 |   Mika Gissler5,6 |   Pirjo Pennanen7 |    
Johan G. Eriksson2,4,8,9 |   Merja K. Laine2,4
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in 
any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
© 2020 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of 
Obstetrics and Gynecology (NFOG)
Abbreviations: BMI, body mass index; CI, confidence intervals; GDM, gestational diabetes mellitus; OR, odds ratio; SD, standard deviation; T2D, type 2 diabetes mellitus.
1Department of Gynecology and Obstetrics, 
University of Helsinki and Helsinki 
University Hospital, Helsinki, Finland
2Department of General Practice and 
Primary Health Care, University of Helsinki 
and Helsinki University Hospital, Helsinki, 
Finland
3Primary Health Care Unit, Kuopio 
University Hospital, Kuopio, Finland
4Folkhälsan Research Center, Helsinki, 
Finland
5Finnish Institute for Health and Welfare 
(THL), Helsinki, Finland
6Karolinska Institute, Stockholm, Sweden
7Vantaa Health Center, Vantaa, Finland
8Department of Obstetrics & Gynecology, 
Yong Loo Lin School of Medicine, National 
University of Singapore, Singapore
9Singapore Institute for Clinical Sciences 
(SICS), Agency for Science, Technology and 
Research (A*STAR), Singapore
Correspondence
Senja Masalin, Department of Gynecology 
and Obstetrics, University of Helsinki, PO 




Research Foundation for Primary Health 
Care, Finland, and The Hospital District of 
Helsinki and Uusimaa, Finland, awarded a 
research grant for this study. Samfundet 
Folkhälsan, Helsinki, Finland has funded the 
study. Senja Masalin received a personal 
research grant from Svenska Kulturfonden, 
Finland.
Abstract
Introduction: Smoking has been shown to affect glucose homeostasis and increase 
the risk for type 2 diabetes mellitus. Further, gestational diabetes mellitus (GDM) 
and smoking are known to influence offspring birthweight. The effect of smoking on 
glucose homeostasis in pregnancy is less studied and the findings are inconsistent. 
The aim of this study was to evaluate the effect of smoking on risk for GDM and to 
evaluate the impact of smoking and GDM on offspring birthweight.
Material and methods: This is an observational cohort study encompassing 4111 
Finnish primiparous women from the city of Vantaa, Finland, who delivered a sin-
gleton child between 2009 and 2015. Data were obtained from Finnish national reg-
isters. Study participants had complete oral glucose tolerance test results and were 
divided into three groups according to smoking status: non-smokers (I), smokers who 
quit during first trimester (II), and smokers who continued after first trimester (III).
Results: Prevalence of GDM was 19.8%, 24.3%, and 26.6% in non-smokers, those 
who quit, and those who continued after the first trimester, respectively (P = .004 
for differences between groups). The odds ratio for GDM in smokers who continued 
after the first trimester compared with non-smokers was 1.65 (95% CI 1.09-2.57) 
after adjustments for age, prepregnancy body mass index, education, and cohabita-
tion. In women without GDM, offspring birthweight was lowest in those who con-
tinued smoking after the first trimester (P = .010 for differences between groups). In 
women with GDM, smoking status did not influence offspring birthweight.
Conclusions: Smoking during pregnancy is associated with an increased risk for 
GDM. Offspring birthweight is lowest in women who continue smoking after the 
first trimester. If pregnancy is complicated by GDM, offspring birthweight is not in-
fluenced by smoking.
K E Y W O R D S
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1  | INTRODUC TION
Gestational diabetes mellitus (GDM) is defined as any kind of ab-
normal glucose metabolism first detected, or with first onset, during 
pregnancy.1 The prevalence of GDM worldwide has been rising dra-
matically during the last decades, making it a serious global health 
issue.2,3 An optimal glucose metabolism during pregnancy is crucial 
for normal fetal development and growth. GDM, and especially un-
treated maternal hyperglycemia, during pregnancy is associated with 
exaggerated fetal growth known as macrosomia.1
Some widely accepted risk factors for GDM are advancing ma-
ternal age, maternal obesity, and a genetic predisposition for type 2 
diabetes mellitus (T2D) or GDM.4 Moreover, maternal short stature, 
maternal low birthweight, and a lower socioeconomic status have 
also been recognized to increase the risk for GDM.3,4 In studies on 
non-pregnant women, smoking has been shown to affect glucose 
homeostasis and increase the risk for T2D.5,6 Interestingly though, 
the effects of smoking on glucose homeostasis in pregnancies are 
less studied and the findings are somewhat conflicting: some stud-
ies show an increased risk for GDM among smokers,7-9 some a de-
creased risk,10 and some studies report no association at all.3,11-13
The prevalence of smoking during pregnancy has been estimated 
to vary between 10.5% and 13% in the early 2000s in USA and 
Sweden.14 In Finland, the prevalence of smoking among pregnant 
women has remained stable at 15% between the years 1991-2015.15 
Smoking during pregnancy is of major concern because it is known 
to increase the risk for severe pregnancy complications such as 
preterm birth, perinatal mortality, and stillbirth.14 Moreover, smok-
ing is inversely associated with offspring birthweight.14 Offspring 
size at birth, in turn, is recognized to have long-lasting effects on 
health over the lifespan.16
In 2016, we initiated a long-term follow-up study in the city of 
Vantaa, Finland, to assess short- and long-term health effects of glu-
cose metabolism on the pregnant women and their offspring. It is 
of interest to study risk factors for GDM, especially those that are 
modifiable, to aim for a more efficient screening and prevention of 
GDM in the future. The objective of this study was to evaluate the 
effects of smoking on glucose homeostasis, and further, to evaluate 
the combined effects of smoking and GDM on offspring birthweight 
in primiparous women.
2  | MATERIAL AND METHODS
This is an observational cohort study from the city of Vantaa, which 
is part of the Helsinki metropolitan area, with 220 000 inhabit-
ants. During a 7-year follow-up, between 1 January 2009 and 31 
December 2015, 7750 primiparous women without a history of di-
agnosed diabetes mellitus gave birth. Of these, 4111 Finnish women 
(born in Finland with Finnish or Swedish as native language) and aged 
≥18 years delivered their first singleton child at term between ges-
tational weeks 37 and 42. All of these women had complete data 
from a standard 2-hour 75-g oral glucose tolerance test (OGTT). We 
included only those women who had complete OGTT results, so as 
to have a reliable diagnosis of GDM in the current pregnancy. This 
was a register-based study with no patient involvement. No identifi-
able personal data were available to the researchers.
Since 2008, the Finnish Current Care Guidelines for GDM rec-
ommend screening of all pregnant primiparous women for GDM 
between gestational weeks 24 and 28 using a standard 2-hour 75-g 
OGTT, except in low-risk women, ie women aged under 25 years, 
with a prepregnancy body mass index (BMI) between 18.5 and 
25 kg/m2, and with no family history of diabetes mellitus.17 If the 
pregnant primiparous woman is considered to be at high risk for 
GDM, that is, with a prepregnancy BMI >35 kg/m2, glucosuria in 
early pregnancy, a family history of T2D, use of oral corticosteroid 
medication, or a history of polycystic ovarian syndrome, the screen-
ing for GDM will have been performed already between gestational 
weeks 12 and 16.17 If the early screening result is not diagnostic, the 
OGTT will be repeated between gestational weeks 24 and 28.
Diagnostic criteria used for the diagnosis of GDM were defined 
according to the Finnish Current Care Guidelines for GDM as one or 
more pathological glucose values in a standard 2-hour 75-g OGTT 
with thresholds as follows: fasting plasma glucose ≥5.3 mmol/L, 
1-hour glucose ≥10.0 mmol/L, and 2-hour glucose ≥8.6 mmol/L.17
Data on maternal-fetal characteristics were obtained from the 
Finnish Medical Birth Register, which is maintained by the Finnish 
Institute for Health and Welfare. The register receives informa-
tion about all live and stillbirths from gestational weeks 22 or with 
a birthweight ≥500 g, from all Finnish maternity hospitals (http://
www.thl.fi/en/stati stics /partu rients). From this source we obtained 
the following information about the primiparous women: pregesta-
tional weight, height, previous pregnancies (including miscarriages, 
induced abortions, and ectopic pregnancies), infertility treatments, 
information about current pregnancies and deliveries, hospitalization 
for hypertension during pregnancy, and smoking during pregnancy. 
More specifically, smoking status was self-reported and documented 
in a structural form at hospitals at time of delivery. According to 
pre-defined smoking categories on the form, the women were di-
vided into three groups with the following definitions: non-smok-
ers (I), smokers who quit during the first trimester of pregnancy (II), 
and smokers who continued after the first trimester of pregnancy 
(III). Additionally, the following information on the offspring was col-
lected: sex, birth length, birthweight, and head circumference.
Offspring birthweights were calculated as Z-scores (according to 
sex and gestational age) within the study cohort.
Key message
Smoking during pregnancy increases risk for gestational 
diabetes mellitus (GDM) but decreases offspring birth-
weight. If the pregnancy is complicated by GDM, offspring 
birthweight is not influenced by smoking.
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Incomplete information about GDM, maternal height, and 
 prepregnancy weight was completed using information from individ-
ual patient records from Vantaa Health Care.
Statistics Finland provided information about educational attain-
ment, according to years of schooling (Official Statistics of Finland: 
http://stat.fi/til/vkour /index_en.html).
2.1 | Statistical analyses
Data in the table are presented as means with range or standard 
deviations (SD) or as counts with percentages. Offspring birthweight 
was calculated as Z-scores (according to sex and gestational age) 
within the study cohort. Statistical comparisons between the three 
groups according to smoking status were performed using analysis 
of variance, and chi-squared tests. Adjusted differences between 
the groups were evaluated using analysis of covariance and logis-
tic models. Models included age, prepregnancy BMI, education, and 
cohabiting as covariates. Hommel's adjustment has been applied to 
correct levels of significance for multiple testing (at significance level 
0.05). The normality of the variables was evaluated graphically and 
by using the Shapiro-Wilk W test. Stata 16.0 (StataCorp LP) statisti-
cal package was used for the analysis.
2.2 | Ethical approval
The present study has been approved by the ethics committee of 
the Hospital District of Helsinki and Uusimaa (356/13/03/03/2015, 
2 November 2015), as well as by the health authority of the city of 
Vantaa, Finland. Finnish Institute for Health and Welfare and Statistics 
Finland gave their permission to use register data for this study. As this 
is an observational register-based study, the study participants do not 
need to provide any Statement of Informed Consent, as outlined by 
the Hospital District of Helsinki and Uusimaa, and the health authority 
of Vantaa city. The study participants were not contacted. Data can-
not be shared for both legal and ethical reasons. Data from the Finnish 
Institute for Health and Welfare, Statistics Finland, and the Finnish 
Social Insurance Institution can only be used for the purpose stated 
in the license granted, scientific research on society by the license ap-
plicant, and can therefore not be shared with third parties.
3  | RESULTS
3.1 | Characteristics of study participants
Characteristics of the 4111 study participants, grouped according to 
smoking status into three groups, are shown in Table 1. The overall 
prevalence of smoking was 15.1%. Of the primiparous women, 8.1% 
were smokers who quit smoking during the first trimester and 7.4% 
of the women were smokers who still continued smoking after the 
first trimester. Age differed between the groups, with non-smokers 
being the oldest (mean age 30.0 [SD 4.5] years) (P < .001 for differ-
ences between groups). Similarly, educational attainment differed 
between the groups with a higher educational attainment in the 
group of non-smokers (P < .001 for differences between groups). 
Prepregnancy BMI was significantly lower in non-smokers compared 
with the two groups of smokers, but did not differ between smokers 
who either quit or continued smoking after the first trimester.





Smokers who quit during 
the first trimester (II)
N = 305
Smokers who continued 
after the first trimester (III)
N = 331
Age (y), mean (SD) 30.0 (4.5) 27.5 (4.7) 26.5 (5.5) <.001 [I/II, I/III, II/III]
Height (cm), mean (range) 166 (6) 166 (6) 166 (6) .30
Prepregnancy weight (kg), mean 
(SD)
67.8 (13.6) 70.6 (14.8) 72.5 (17.0) <.001 [I/II, I/III]
Cohabiting, n (%) 2919 (84) 235 (77) 228 (69) <.001 [I/II, I/III, II/III]
Education years, mean (SD) 14.2 (2.3) 12.7 (2.1) 11.2 (2.1) <.001 [I/II, I/III, II/III]
Prepregnancy BMI (kg/m2), 
mean (SD)
24.6 (4.6) 25.7 (5.0) 26.3 (5.6) <.001 [I/II, I/III]
Previous pregnancies, n (%) 638 (18) 77 (25) 103 (31) <.001 [I/II, I/III]
Fertility treatment, n (%) 384 (11) 10 (3) 8 (2) <.001 [I/II, I/III]
Hypertensive disordersb  224 (6) 27 (9) 17 (5) .15
Cesarean delivery, n (%) 800 (23) 74 (24) 71 (22) .75
Abbreviations: BMI, body mass index; SD, standard deviation.
aP-value for differences between groups; Hommel's multiple comparison procedure was used to correct significance levels for post hoc testing 
(P < .05). 
bHospitalization for hypertension during pregnancy. 
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3.2 | Smoking status and prevalence of GDM
The overall prevalence of GDM in the study cohort was 20.7%. In the 
group of non-smokers, the prevalence was 19.8%, whereas, in both 
groups of smokers the prevalence was higher: 24.3% in those who 
quit, and 26.6% in those who continued after the first trimester, re-
spectively (P = .004 for differences between groups). The differences 
between groups also remained significant after adjustments for age, 
prepregnancy BMI, education, and cohabiting (P = .028) (Figure 1).
Similarly, the odds ratio (OR) for GDM in the group of smokers 
who continued after the first trimester compared with non-smok-
ers was 1.65 (95% CI 1.09-2.47) after adjustments for age, pre-
pregnancy BMI, education, and cohabiting. The OR for GDM 
in smokers who quit during the first trimester compared with 
non-smokers was 1.24 (95% CI 0.90-1.72), after adjustments for 
the same confounders.
3.3 | Smoking status and its effect on OGTT values
The effect of smoking status on glucose concentrations after an 
OGTT in the three groups was evident both on fasting glucose 
concentrations (P = .013) and 1-hour postprandial glucose concen-
trations (P = .002), after adjustments for age, prepregnancy BMI, 
education, and cohabiting (Figure 2). Smoking status did not affect 
2-hour postprandial glucose concentrations (P = .10), after adjust-
ments for the same confounders (Figure 2).
3.4 | Effect of smoking status and GDM 
on offspring birthweight
Figure 3 shows the impact of maternal smoking status and GDM 
and their interaction on offspring birthweight, adjusted for mater-
nal age and prepregnancy BMI. Independently, GDM did not affect 
offspring birthweight across the three groups, whereas smoking did, 
and the interaction between GDM and smoking was significant. In 
primiparous women without GDM, offspring birthweight was lower 
in the group of smokers who continued after the first trimester. 
However, in primiparous women with GDM, smoking did not influ-
ence offspring birthweight, not even in the group of smokers who 
continued after the first trimester.
F I G U R E  1   Prevalence of gestational diabetes mellitus (GDM) 
according to smoking status. Prevalence of GDM according to 
smoking status after adjustments for age, prepregnancy body mass 
index, education, and cohabiting. The three groups were defined 
as follows: non-smokers (I), smokers who quit during the first 
trimester (II), and smokers who continued after the first trimester 
(III). Whiskers represent 95% confidence intervals
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4  | DISCUSSION
The overall prevalence of GDM in the study cohort was 20.7% and 
overall GDM prevalence was associated with smoking status. Non-
smokers had significantly lower fasting and 1-hour glucose con-
centrations compared with smokers who continued smoking after 
the first trimester. However, 2-hour glucose concentrations did not 
differ between smokers and non-smokers. In primiparous women 
without GDM, offspring birthweight was lower in those who contin-
ued smoking after the first trimester compared with non-smokers. 
However, in women with GDM, smoking status did not influence 
offspring birthweight.
The prevalence of GDM in the study cohort of 21% must be 
considered high, as the highest reported nationwide prevalence of 
GDM during the same study period was 16%.18 The high prevalence 
is likely because the cohort consisted of women with complete data 
from OGTT, who are regarded as being at high-risk for GDM. The 
15% prevalence of smokers in the beginning of pregnancy is in line 
with findings from Finland in general.15
The relation between smoking and T2D has been widely studied 
and a positive association between smoking and risk of T2D has been 
verified in two recent systematic reviews.5,6 Further, WHO has newly 
endorsed smoking as a modifiable risk factor in prevention of T2D.19 
The association between smoking and GDM is, however, more con-
troversial. Several epidemiological studies have assessed the relation 
showing positive,7-9 negative,10 and neutral3,12 relations. A systematic 
review from 2008 reported no significant association between smok-
ing and GDM,11 however, the number of included studies was low and 
most of them were based on unadjusted measurements. In 2018, none-
theless, Wang et al published a meta-analysis with the same findings.13
We found smoking to be associated with an increased risk for 
GDM. Comparisons between the above-mentioned studies with 
mixed findings regarding the relation between smoking and GDM 
must be considered carefully. Most importantly, smoking status of 
the pregnant women has mostly been self-reported and assessed in 
different manners depending on the study. Second, diagnostic crite-
ria for GDM vary between studies, and finally, analyses have been 
performed with different confounding factors. It is, for example, 
of great importance to recognize the confounding effects of socio-
economic factors and weight gain after smoking cessation in early 
pregnancy,20 as both excessive weight gain21 and socioeconomic 
deprivation, which smoking can be related to, are known to increase 
the risk for GDM.3 In a meta-analysis by Wang et al assessing the ef-
fect of smoking cessation in early pregnancy, the authors concluded 
that most of the included studies adjusted for BMI or gestational 
weight gain, which might attenuate the increased risk for GDM.13 
On the other hand, in a cohort study showing no effect of smoking 
on GDM, Anna et al controlled, among other variables, for age and 
socioeconomic status, but not for obesity.3 One can only speculate 
how the selection of possible confounders affects the relation be-
tween smoking and gestational diabetes.
Chronic cigarette smoking increases insulin resistance through a 
direct effect on insulin-mediated glucose uptake as well as on pancre-
atic β-cell function and insulin secretion.6 Acute effects on glucose 
homeostasis and elevated postprandial glucose concentrations can, at 
least to some extent, be caused by a decreased gastric emptying in 
F I G U R E  2   The effect of smoking status on oral glucose tolerance test (OGTT) values. The effect of smoking status on OGTT values. The 
three different groups were defined as follows: non-smokers (I), smokers who quit during the first trimester (II), and smokers who continued 
after the first trimester (III). Models were adjusted for age, prepregnancy body mass index, education, and cohabiting. Whiskers represent 
95% confidence intervals. Abbreviations: 1hPG, 1-hour plasma glucose; 2hPG, 2-hour plasma glucose; FPG, fasting plasma glucose
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smokers.22 A study from the 1980s showed that smokers had higher 
1-hour postprandial glucose concentrations compared with non-smok-
ers, but lower 2-hour postprandial glucose concentrations.23 A recent 
meta-analysis also reported 2-hour postprandial concentrations to be 
lower in smokers compared with non-smokers.24 Likewise, also in preg-
nant women with GDM, 1-hour postprandial concentrations have been 
shown to be higher and 2-hour postprandial concentrations lower in 
women who smoked at the beginning of their pregnancy compared 
with non-smokers.25 None of these previous studies have reported 
any difference in fasting glucose concentrations.
To the best of our knowledge, few studies have evaluated the re-
lation between smoking and glucose concentrations after an OGTT 
during pregnancy.7,25 Compared with non-smokers, we discovered 
that primiparous women who continued smoking after the first tri-
mester, had higher fasting glucose concentrations and higher 1-hour 
glucose concentrations. Women who stopped smoking after the first 
trimester, also had higher fasting glucose concentrations but not 
higher 1-hour glucose concentrations. The 2-hour concentrations 
showed a trend towards lower concentrations in smokers compared 
with non-smokers. Considering that the OGTT is mostly performed 
during the latter part of the second trimester, this could suggest that 
the adverse effects of smoking on glucose homeostasis could be 
reversible to some extent already during pregnancy. This idea gets 
support from a previous study, as chronic cigarette smokers were 
shown to have lower insulin sensitivity compared with non-smokers, 
which improved, but did not normalize after 1-2 weeks of smoking 
cessation.26
As a well-accepted phenomenon,14 we also found offspring birth-
weight to be lowest in women who continued smoking after the first 
trimester compared with non-smokers. A low offspring birthweight 
in smokers is thought to be caused by restricted fetal oxygenation 
and nutrition transfer due to binding of nicotine and carbon monox-
ide to uterine artery blood flow and fetal hemoglobin.14 Moreover, 
a possible interaction between maternal metabolic genes and ciga-
rette smoking with regard to fetal growth has also been reported.14 
The adverse effects of smoking are, at least to some degree, be-
lieved to be reversible during pregnancy as the birthweights of off-
spring born to women who stopped smoking early in pregnancy are 
similar to those of offspring of non-smokers.27 Similarly, according 
to our findings, offspring birthweight was not lower in those women 
who stopped smoking during the first trimester of their pregnancy.
One previous study evaluated the relation between smoking sta-
tus, glucose homeostasis and offspring birthweight.7 Similar to our 
findings, smoking seemed to affect parameters of glucose homeo-
stasis in the direction of GDM as they showed glycated hemoglobin 
to be higher in heavily smoking pregnant women. Zaren et al also 
reported offspring birthweight to be low in heavily smoking moth-
ers. However, in contrast to our findings, they reported offspring 
birthweight to be low also in those smoking mothers with higher 
glucose concentrations.7 Interestingly, these women were thinner 
and shorter, which could, at least partly, be a confounding factor and 
affect the size of their newborn as maternal anthropometry is known 
to affect offspring size at birth.28 In our study cohort, women who 
smoked had a higher prepregnancy BMI. This could, possibly, be ex-
plained by a lower degree of educational attainment, which in turn, 
is inversely associated with BMI.29
The study has several strengths. It is comprehensive and encom-
passes all adult Finnish primiparous women from the city of Vantaa 
with complete data from a standard 2-hour 75- g OGTT who deliv-
ered their first child during a 7-year follow-up period. The diagnosis 
F I G U R E  3   Impact of smoking status and gestational diabetes 
mellitus (GDM) on offspring birthweight. The impact of smoking 
and GDM and their interaction on offspring birthweight in three 
different groups depending on smoking status, adjusted for age, 
prepregnancy body mass index, education, and cohabiting. The 
three groups were defined as follows: non-smokers (I), smokers 
who quit during the first trimester (II), and smokers who continued 
after the first trimester (III). Offspring birthweight was calculated as 
Z-scores according to sex and gestational age. Whiskers represent 
95% confidence intervals
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of GDM is trustworthy, it is based upon a standardized 2-hour 75-g 
OGTT and the diagnostic criteria have remained the same during the 
study period. Further, only primiparas were included in this study 
to exclude the confounding effects of previous GDM or multiparity 
on the risk for GDM. Finally, data from the Finnish Medical Birth 
Register can be considered of high quality.30
The study also has some limitations. Information about smok-
ing status was self-reported and the number of cigarettes smoked 
per day was unknown. Also, we had no information on smoking 
status before pregnancy. Moreover, we lacked information about 
some well-known risk factors for GDM such as gestational weight 
gain and family history of diabetes. Finally, the study cohort in-
cluded only women born in Finland and speaking either Finnish or 
Swedish, therefore generalization of the results globally might be 
restricted.
5  | CONCLUSION
Smoking during pregnancy is associated with an increased risk for 
GDM. Offspring birthweight is lowest in those women who con-
tinue smoking after the first trimester of pregnancy. However, if the 
pregnancy is complicated by GDM, offspring birthweight is not influ-
enced by smoking. Smoking cessation should be highly encouraged 
in all pregnancies, taking the possible reversible adverse effects of 
smoking on both glucose homeostasis and offspring birthweight into 
account. Further studies are needed to evaluate the possible mech-
anisms and interaction between smoking and GDM on offspring 
birthweight, also taking socioeconomic factors and pregnancy 
weight gain into account.
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